The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...
The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback